Wcm Investment Management, LLC Ligand Pharmaceuticals Inc Transaction History

Wcm Investment Management, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 26, 2022	SELL	$127.69 - $165.85 $3.84 Million - $4.99 Million	-30,068 Closed	0 $0
Q3 2021 Nov 02, 2021	BUY	$102.33 - $144.73 $15,042 - $21,275	147 Added 0.49%	30,068 $4.19 Million
Q2 2021 Aug 05, 2021	BUY	$113.03 - $155.64 $123,767 - $170,425	1,095 Added 3.8%	29,921 $3.93 Million
Q1 2021 May 13, 2021	SELL	$99.52 - $215.83 $3.86 Million - $8.38 Million	-38,818 Reduced 57.39%	28,826 $4.4 Million
Q4 2020 Feb 16, 2021	BUY	$80.55 - $106.05 $2.32 Million - $3.06 Million	28,837 Added 74.31%	67,644 $6.73 Million
Q3 2020 Nov 06, 2020	BUY	$89.56 - $126.72 $217,093 - $307,169	2,424 Added 6.66%	38,807 $3.7 Million
Q2 2020 Aug 18, 2020	BUY	$68.28 - $123.65 $201,903 - $365,633	2,957 Added 8.85%	36,383 $4.07 Million
Q1 2020 May 08, 2020	BUY	$63.37 - $107.88 $607,021 - $1.03 Million	9,579 Added 40.17%	33,426 $2.43 Million
Q4 2019 Feb 07, 2020	BUY	$96.94 - $113.59 $1.75 Million - $2.05 Million	18,016 Added 308.97%	23,847 $2.49 Million
Q2 2019 Aug 06, 2019	BUY	$107.38 - $129.34 $319,670 - $385,045	2,977 Added 104.31%	5,831 $666,000
Q1 2019 May 13, 2019	BUY	$105.93 - $142.47 $302,324 - $406,609	2,854 New	2,854 $359,000

255

18.1M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.87B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Wcm Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Wcm Investment Management, LLC with notifications on news.